Article
Cellular normoxic biophysical markers of hydroxyurea treatment in sickle cell disease
10 Aug 2016
Abstract excerpt
Hydroxyurea (HU) has been used clinically to reduce the frequency of painful crisis and the need for blood transfusion in sickle cell disease (SCD) patients. However, the mechanisms underlying such beneficial effects of HU treatment are still not fully understood. Studies have indicated a weak correlation between clinical outcome and molecular markers, and the scientific quest to develop companion biophysical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
